Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 70518-4551

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 70518-4551). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Bupropion Hydrochloride XL 300 mg extended-release tablets in a quantity of 90 tablets. The label indicates the product is repackaged by RemedyRepack Inc. and includes storage instructions, the NDC number 70518-4551-00, and mentions the product is prescription-only. The original manufacturer is Westminster Pharmaceuticals, LLC.*
FDA Label Image

Structural-formula (Structural Formula)

Structural-formula (Structural Formula)
Chemical structure of bupropion hydrochloride showing a chlorophenyl group attached to a ketone and a tert-butylamino group, with a hydrochloride indicated as a separate component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.